We are delighted to announce that OXOART2, the OXO-001 phase II clinical trial, has already started!
As mentioned by the newspapers Expansion and LaVanguardia, this trial aims to demonstrate the efficacy of OXO-001 in promoting embryo implantation in assisted reproduction treatments. The study will be conducted with 351 women in 24 sites of Spain, the Czech Republic, and Poland. The 13 Spanish centers selected to participate in this trial are IVI Valencia, IVI Madrid, IVI Bilbao, IVI Barcelona, Hospital Universitari Dexeus, Ginemed Sevilla, Hospital U. Quirónsalud Barcelona, Hospital U. Quirónsalud Madrid, IVI Zaragoza, GINEFIV Madrid, Instituto Bernabeu Alicante, IVI Mallorca and Instituto Bernabeu Madrid. To date, this is the most important phase II study on the subject carried out in Spain. We are thrilled for reaching such a big milestone!